Trim to 2% max; Underweight on confirmed MACD bearish crossover, price below VWMA by $6.50, contracting bounce volume, and 18% ATR expansion signaling elevated volatility.
Underweight rating reflects convergence of confirmed MACD bearish crossover (histogram -2.32 and expanding), price $6.50 below VWMA, contracting bounce volume (3.18M vs 4.3M average), and 18% ATR expansion. Forward P/E of 22.72x represents real premium to S&P 500's ~21-22x. Position capped at 2% due to 72% concentration in 5 megacap tech names creating S&P 500 proxy correlation not reflected in historical 0.607 beta. Full exit not warranted as 200 SMA structural floor intact and buyback resumption signals Abel regime shift potential.
| Position | Action |
|---|---|
| Default allocation until setup resolves | Maximum 2% portfolio allocation to BRK-B |
| Confirmed close below $491 on volume >4M | Escalate to full Sell, target $465-475 |
| Q3 2026 buyback pace at or above $4.21B/quarter | Shift toward Hold/Overweight |
| Volume-confirmed VWMA reclaim at $510 with MACD histogram contracting toward zero | Enable staged reload |
BRK-B's recent pullback is a healthy correction, not a breakdown—the technical "pause" is the setup for appreciation as the market re-rates Berkshire from "cash-rich but inert" to "cash-rich and actively compounding" under Greg Abel's leadership.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 503.48 | bearish |
| 50 SMA | 500.76 | bullish |
| 200 SMA | 492.21 | bullish |
| RSI (14) | 50.12 | neutral |
| MACD | -0.17 | bearish |
| MACD Signal | 2.16 | bearish |
| MACD Histogram | -2.32 | bearish |
| Bollinger Middle Band | 510.15 | bearish |
| Bollinger Upper Band | 528.88 | neutral |
| Bollinger Lower Band | 491.42 | neutral |
| ATR (14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed VWMA reclaim at $510 with histogram contracting toward zero
Then: Stage reload of BRK-B position
Technical bear case is built on noise, not signal—the pullback is a healthy correction, not a breakdown
↩ rebuts: “MACD bearish signal, $6.50 below VWMA, light volume bounce”
· concedes: The technical analyst's recommendation to wait for a pullback to $491-495 is fine risk management for a tactical trader
BRK-B is not a stable compounder but a leveraged equity bet wrapped in an insurance shell, currently forming a distribution top with a bearish MACD crossover, deteriorating balance sheet, unproven capital allocation under Abel, and concentrated megacap tech exposure at a leadership rotation moment.
EV: -$45 to $25 (downside to $465-475 zone vs limited upside to $529) · concedes: Q2 2026 net income and EPS did double year-over-year; Cash position of $365.5B remains substantial; Bill Gates Foundation #1 holding demonstrates institutional confidence; 50 SMA ($500.76) and 200 SMA ($492.21) still in bullish stacking order
→ vs neutral: The neutral 'wait for pullback to $491-$495 to add' advice is 'analysis paralysis that bleeds portfolios dry' — the waiting trader will face 3-5% gap-down moves with no good entry by the time confirmation arrives; the bearish MACD (-2.32), VWMA violation ($6.50 below), and volume contraction (3.18M vs 4.3M) are already visible warning signs that argue for acting now, not waiting
→ vs conservative: The conservative instinct to dismiss weak earnings as 'lumpy' is 'exactly backward' — the lumpiness argues FOR caution because the $14.85B of Other Income driving Q2 2026's 107% net income gain is mark-to-market noise, making the 22.72x forward P/E a premium valuation to S&P 500, not a discount
→ vs conservative: The 6.1/10 mildly bullish sentiment with LOW confidence is 'neutral reading dressed up in optimistic language' — the bullish case rests entirely on derivative news coverage with massive duplication and zero Reddit engagement, providing no real upside conviction
| 7.57 |
| neutral |
| VWMA | 510.80 | bearish |
Support: 500.76 · 495.82 · 491.42 · 492.21 · 474 · 478 | Resistance: 503.48 · 510.15 · 510.8 · 528.88
BRK-B exhibits conflicting signals: long-term trend remains constructive with price above 200 SMA by +2.5%, but short-term momentum has rolled over with bearish MACD crossover and price below VWMA. RSI has reset from overbought (74.54 on Aug-10) to neutral (50.12). ATR expanded to 7.57 from ~6.4 in late July. Support confluence at $491-$492 (200 SMA + lower Bollinger) represents highest-conviction buy zone; resistance at $510.15-$510.80 (Bollinger mid/VWMA) must be reclaimed for bulls to regain control. Recommendation: HOLD; existing longs should maintain stops near $491-$492; new entries should wait for pullback to $491-$495 with confirming reversal candle.
Market Cap
$1.0796 Trillion
Beta
0.607
P/E (TTM)
12.68x
Forward P/E
22.72x
Price/Book
~0.9657
EPS (TTM)
$39.76
52-Week High
$537.74
52-Week Low
$464.01
50-Day Moving Avg
$500.39
200-Day Moving Avg
$492.12
Revenue (TTM)
$384.69B
Gross Profit
$116.68B
EBITDA
$130.68B
Net Income (TTM)
$85.77B
Operating Margin
32.56%
Net Profit Margin
22.30%
Return on Equity (ROE)
12.12%
Return on Assets (ROA)
6.01%
Total Assets
$1.263 Trillion
Stockholders' Equity
$747.91B
Tangible Book Value
$630.79B
Cash + ST Investments
$365.51B
Total Debt
$128.60B
Long-Term Debt
$125.94B
Net Debt
$87.99B
Debt-to-Equity (Long-term basis)
16.8%
Current Ratio
2.89
Equity Investments
$323.78B
Other Investments
$685.67B
Free Cash Flow (TTM)
$71.97B
Q2 2026 Revenue
$117.89B
Q2 2026 Net Income
$25.67B
Q2 2026 Diluted EPS
$11.91
Q2 2026 Pretax Income
$32.06B
Q1 2026 Revenue
$92.07B
Q1 2026 Net Income
$10.11B
Q1 2026 Diluted EPS
$4.68
Q2 2026 Share Buybacks
$4.21B
H1 2026 Net Income
$35.78B
Q2 2026 Operating Cash Flow
$11.22B
Q2 2026 CapEx
$5.65B
Annual 2025 Revenue
$410.52B
Annual 2025 Net Income
$66.97B
Annual 2025 Diluted EPS
$31.04
Annual 2024 Revenue
$424.23B
Annual 2024 Net Income
$89.00B
Annual 2024 Diluted EPS
$41.27
Annual 2023 Revenue
$439.34B
Annual 2023 Net Income
$96.22B
Annual 2023 Diluted EPS
$44.27
Annual 2022 Revenue
$234.12B
Annual 2022 Net Income
-$22.76B
Annual 2022 Diluted EPS
-$10.33
Strengths
Concerns
Berkshire Hathaway (BRK-B) is a diversified conglomerate spanning property & casualty insurance, freight rail (BNSF), utilities (BHE), and a massive equity/fixed-income investment portfolio, currently trading at a significant valuation discount (12.68x TTM P/E) to the S&P 500 (~21–22x). The Q2 2026 earnings blowout ($25.67B net income, $11.91 EPS, +107.5% YoY) was largely driven by elevated investment portfolio gains ($14.85B in Other Income/Expense), not sustainable operating momentum, so traders should avoid extrapolating this quarterly beat. The fortress balance sheet ($365.51B liquidity vs $128.60B debt), resumed buyback program, and defensive low-beta (0.607) profile make BRK-B an attractive long-term hold, though the stock is best approached near the 50-day moving average ($500.39) with the 200-day ($492.12) as a downside support level to monitor.
Macro: Soft-landing consensus firmly entrenched: Polymarket prices only 8% US recession probability by end-2026 and 86% implied probability of zero Fed cuts in 2026 (up +1.2pp WoW). The "higher-for-longer" rate regime is a tailwind for Berkshire's $364.7B cash/T-bill float (earning ~5% yield = ~$18B+ in annual float income), but creates mark-to-market headwinds for the equity-heavy portfolio. Gold closed at $4,640.80 (+0.36%) and silver is +18% MoM — bullish for Berkshire's commodity/energy exposure. FRED macro series unavailable; analysis anchored on prediction-market probabilities.